BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 15751056)

  • 1. Classification analysis of the transcriptosome of nonlesional cultured dermal fibroblasts from systemic sclerosis patients with early disease.
    Tan FK; Hildebrand BA; Lester MS; Stivers DN; Pounds S; Zhou X; Wallis DD; Milewicz DM; Reveille JD; Mayes MD; Jin L; Arnett FC
    Arthritis Rheum; 2005 Mar; 52(3):865-76. PubMed ID: 15751056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased levels of transforming growth factor beta receptor type I and up-regulation of matrix gene program: A model of scleroderma.
    Pannu J; Gardner H; Shearstone JR; Smith E; Trojanowska M
    Arthritis Rheum; 2006 Sep; 54(9):3011-21. PubMed ID: 16947635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monozygotic twins clinically discordant for scleroderma show concordance for fibroblast gene expression profiles.
    Zhou X; Tan FK; Xiong M; Arnett FC; Feghali-Bostwick CA
    Arthritis Rheum; 2005 Oct; 52(10):3305-14. PubMed ID: 16200604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of gene expression patterns in systemic sclerosis fibroblasts using RNA arbitrarily primed-polymerase chain reaction for differential display.
    Meyringer R; Neumann E; Judex M; Landthaler M; Kullmann F; Scholmerich J; Gay S; Tarner IH; Distler O; Müller-Ladner U
    J Rheumatol; 2007 Apr; 34(4):747-53. PubMed ID: 17407232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monocyte chemoattractant protein 3 as a mediator of fibrosis: Overexpression in systemic sclerosis and the type 1 tight-skin mouse.
    Ong VH; Evans LA; Shiwen X; Fisher IB; Rajkumar V; Abraham DJ; Black CM; Denton CP
    Arthritis Rheum; 2003 Jul; 48(7):1979-91. PubMed ID: 12847692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of novel polymorphisms with the expression of SPARC in normal fibroblasts and with susceptibility to scleroderma.
    Zhou X; Tan FK; Reveille JD; Wallis D; Milewicz DM; Ahn C; Wang A; Arnett FC
    Arthritis Rheum; 2002 Nov; 46(11):2990-9. PubMed ID: 12428242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia-induced increase in the production of extracellular matrix proteins in systemic sclerosis.
    Distler JH; Jüngel A; Pileckyte M; Zwerina J; Michel BA; Gay RE; Kowal-Bielecka O; Matucci-Cerinic M; Schett G; Marti HH; Gay S; Distler O
    Arthritis Rheum; 2007 Dec; 56(12):4203-15. PubMed ID: 18050252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of granulocyte macrophage-colony stimulating factor on extracellular matrix deposition by dermal fibroblasts from patients with scleroderma.
    Postiglione L; Ladogana P; Montagnani S; di Spigna G; Castaldo C; Turano M; Bruno EM; Di Meglio F; Riccio A; Rossi G
    J Rheumatol; 2005 Apr; 32(4):656-64. PubMed ID: 15801021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of interleukin-21 receptor in epidermis from patients with systemic sclerosis.
    Distler JH; Jüngel A; Kowal-Bielecka O; Michel BA; Gay RE; Sprott H; Matucci-Cerinic M; Chilla M; Reich K; Kalden JR; Müller-Ladner U; Lorenz HM; Gay S; Distler O
    Arthritis Rheum; 2005 Mar; 52(3):856-64. PubMed ID: 15751077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between enhanced type I collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblasts.
    Wang Y; Fan PS; Kahaleh B
    Arthritis Rheum; 2006 Jul; 54(7):2271-9. PubMed ID: 16802366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence of 5-lipoxygenase overexpression in the skin of patients with systemic sclerosis: a newly identified pathway to skin inflammation in systemic sclerosis.
    Kowal-Bielecka O; Distler O; Neidhart M; Künzler P; Rethage J; Nawrath M; Carossino A; Pap T; Müller-Ladner U; Michel BA; Sierakowski S; Matucci-Cerinic M; Gay RE; Gay S
    Arthritis Rheum; 2001 Aug; 44(8):1865-75. PubMed ID: 11508440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of multiple, differentially expressed messenger RNAs in dermal fibroblasts from patients with systemic sclerosis.
    Feghali CA; Wright TM
    Arthritis Rheum; 1999 Jul; 42(7):1451-7. PubMed ID: 10403273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblast expression of the coactivator p300 governs the intensity of profibrotic response to transforming growth factor beta.
    Bhattacharyya S; Ghosh AK; Pannu J; Mori Y; Takagawa S; Chen G; Trojanowska M; Gilliam AC; Varga J
    Arthritis Rheum; 2005 Apr; 52(4):1248-58. PubMed ID: 15818659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in gene expression profiles in dermal fibroblasts from control and patients with age-related macular degeneration elicited by oxidative injury.
    Strunnikova N; Hilmer S; Flippin J; Robinson M; Hoffman E; Csaky KG
    Free Radic Biol Med; 2005 Sep; 39(6):781-96. PubMed ID: 16109308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of stromal cell-derived factor 1 and its receptor CXCR4 in the skin and endothelial cells of systemic sclerosis patients: Pathogenetic implications.
    Cipriani P; Franca Milia A; Liakouli V; Pacini A; Manetti M; Marrelli A; Toscano A; Pingiotti E; Fulminis A; Guiducci S; Perricone R; Kahaleh B; Matucci-Cerinic M; Ibba-Manneschi L; Giacomelli R
    Arthritis Rheum; 2006 Sep; 54(9):3022-33. PubMed ID: 16948134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constitutively phosphorylated Smad3 interacts with Sp1 and p300 in scleroderma fibroblasts.
    Ihn H; Yamane K; Asano Y; Jinnin M; Tamaki K
    Rheumatology (Oxford); 2006 Feb; 45(2):157-65. PubMed ID: 16319104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antiangiogenic tissue kallikrein pattern of endothelial cells in systemic sclerosis.
    Giusti B; Serratì S; Margheri F; Papucci L; Rossi L; Poggi F; Magi A; Del Rosso A; Cinelli M; Guiducci S; Kahaleh B; Matucci-Cerinic M; Abbate R; Fibbi G; Del Rosso M
    Arthritis Rheum; 2005 Nov; 52(11):3618-28. PubMed ID: 16255054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I interferons and toll-like receptor agonists.
    York MR; Nagai T; Mangini AJ; Lemaire R; van Seventer JM; Lafyatis R
    Arthritis Rheum; 2007 Mar; 56(3):1010-20. PubMed ID: 17328080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct expression of adhesion molecules on skin fibroblasts from patients with diffuse and limited systemic sclerosis. A pilot study.
    Iannone F; Matucci-Cerinic M; Falappone PC; Guiducci S; Cinelli M; Distler O; Lapadula G
    J Rheumatol; 2005 Oct; 32(10):1893-8. PubMed ID: 16206343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A CD40-CD154 interaction in tissue fibrosis.
    Kawai M; Masuda A; Kuwana M
    Arthritis Rheum; 2008 Nov; 58(11):3562-73. PubMed ID: 18975310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.